HIV and pregnancy

British Medical Journal

Volumn 334, Issue 7600, 2007, Pages 950-953

  Gray, Glenda E ^a   McIntyre, James A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ANEMIA; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; COMBINATION CHEMOTHERAPY; CONDYLOMA ACUMINATUM; DISEASE COURSE; DRUG SUBSTITUTION; EPISIOTOMY; FEVER; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABOR; LACTIC ACIDOSIS; MATERNAL MORTALITY; MATERNAL WELFARE; MEDICAL CARE; MONOTHERAPY; MOTHER CHILD RELATION; NEURAL TUBE DEFECT; NONHUMAN; PATIENT COUNSELING; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; SEPSIS; SURVIVAL; TUBERCULOSIS; URINARY TRACT INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PERINATAL CARE; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

EID: 34249339092     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39176.674977.AD     Document Type: Article

References (10)

1. Mofenson LM. Mother-child HIV-1 transmission: timing and determinants. Obstet Gynecol Clin North Am 1997;24:759-84.
2. Gray GE, McIntyre JA. Effect of HIV on women. AIDS Reader 2006;16:365-8, 373-7.
3. Saada M, Le Chenadec J, Berrebi A, Bongain A, Delfraissy JF, Mayaux MJ, et al. Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000;14:2355-60.
4. Burns DN, Nourjah P, Minkoff H, Korelitz J, Biggar RJ, Landesman S, et al. Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol 1996;174:1461-8.
5. Tuomala RE, Kalish LA, Zorilla C, Fox H, Shearer W, Landay A, et al. Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol 1997;89:967-74.
6. Lewis G. Confidential enquiries into maternal deaths: beyond the numbers: reviewing maternal deaths and complications to make pregnancy safer. Geneva: World Health Organization, 2004:77-102.
7. Mofenson LM. Efavirenz reclassified as FDA pregnancy category D. AIDS Clin Care 2005;17(2):17.
8. US Food and Drug Administration. FDA Public Health Advisory for Nevirapine (Viramune). 19 January 2005. www.fda.gov/cder/drug/advisory/ nevirapine.htm.
9. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Medicine 2001;2:314-34.
10. World Health Organization. New data on the prevention of mother-to-child transmission of HIV and their policy implications, conclusions, and recommendations. WHO technical consultation on behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV, Geneva, 11-13 October 2000. Geneva: WHO, 2001.